Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
VERI - Veritone Inc - Stock Price Chart
CompanyVeritone Inc
IndustrySoftware - Infrastructure
Market Cap75.56MEPS (ttm)-2.14
P/E-EPS this Y-109.66%
Forward P/E-EPS next Y62.74%
PEG-EPS past 5Y35.18%
P/S0.55EPS next 5Y-
P/B4.03EPS Q/Q-391.41%
Dividend-Sales Q/Q-5.55%
Insider Own13.63%Inst Own37.21%
Insider Trans0.99%Inst Trans1.24%
Short Float15.40%EarningsMar 12/a
Analyst Recom3.50Target Price2.09
Avg Volume370.48K52W Range1.48 - 8.40
Veritone, Inc. engages in the provision of artificial intelligence (AI) computing solutions to media and entertainment, government, and legal and compliance industries. It operates through the following segments: Advertising, aiWARE SaaS Solutions, and aiWARE Content Licensing and Media Services. The Advertising segment places advertisements for clients, primarily with radio broadcasters, podcasters and digital media producers. The aiWARE SaaS Solutions segment offers solutions through a combination of its direct sales force and indirect channel partners, such as value-added resellers (VARs), distributors, system integrators, managed services providers, and referral partners. The aiWARE Content Licensing and Media Services segment sells and markets activities relating to its digital content licensing services business through its direct sales force. The company was founded by Chad Edward Steelberg and Ryan S. Steelberg on June 13, 2014 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Steelberg RyanPresident and CEONov 17Buy2.0549,752101,992215,174Nov 20 05:48 PM
QBTS - D-Wave Quantum Inc - Stock Price Chart
CompanyD-Wave Quantum Inc
IndustryComputer Hardware
Market Cap205.25MEPS (ttm)-0.64
P/E-EPS this Y-17.67%
Forward P/E-EPS next Y17.79%
PEG-EPS past 5Y-
P/S24.88EPS next 5Y-
P/B31.96EPS Q/Q-5.79%
Dividend-Sales Q/Q51.15%
Insider Own10.84%Inst Own30.55%
Insider Trans-0.19%Inst Trans13.73%
Short Float4.49%EarningsNov 09/b
Analyst Recom1.00Target Price2.55
Avg Volume2.45M52W Range0.40 - 3.20
D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company's quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nguyen DianeGeneral CounselOct 16Sale1.0022,85522,855254,643Oct 18 04:05 PM
Michael EmilDirectorJun 15Sale1.8629,02153,89236,353Jun 20 04:31 PM
Brydon VictoriaSee RemarksJun 09Option Exercise0.9115,00013,650347,800Jun 13 09:22 PM
Brydon VictoriaSee RemarksJun 09Sale2.3915,00035,850332,800Jun 13 09:22 PM
MYMD - MyMD Pharmaceuticals Inc - Stock Price Chart
CompanyMyMD Pharmaceuticals Inc
Market Cap6.91MEPS (ttm)-5.56
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y73.50%
P/S-EPS next 5Y-
P/B0.34EPS Q/Q167.84%
Dividend-Sales Q/Q-
Insider Own14.68%Inst Own10.42%
Insider Trans95.66%Inst Trans-
Short Float4.50%Earnings-
Analyst Recom1.00Target Price32.00
Avg Volume59.54K52W Range2.81 - 70.50
Feb-13-24 11:45AM MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing (Business Wire) -14.49%
Dec-29-23 12:45PM MyMD Pharmaceuticals Releases Positive Clinical Trial Results For Sarcopenia Treatment Drug (ACCESSWIRE)
Dec-06-23 09:15AM MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis (Business Wire) -5.75%
Oct-19-23 09:00AM MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD, Reduced Acute Inflammatory Pain (Business Wire)
Oct-04-23 07:30AM MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF- Market Disrupter, at BioFuture 2023 (Business Wire)
Aug-14-23 08:30AM FDA Accepts MyMD Pharmaceuticals Investigational New Drug Application (IND) for Phase 2 Study of oral TNF- inhibitor MYMD-1® in Rheumatoid Arthritis (RA) (Business Wire) -7.64%
Aug-02-23 08:30AM MyMD Pharmaceuticals to Hold Conference Call Today to Discuss Phase 2 Trial Results (Business Wire)
Jul-31-23 09:00AM MyMD Pharmaceuticals Reports Statistically Significant Positive Topline Phase 2 Results for Next Generation Oral TNF- Inhibitor MYMD-1® in Sarcopenia/Age-Related Frailty (Business Wire) +31.82%
Apr-12-23 08:30AM MyMD Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan (Business Wire) -8.54%
Mar-20-23 08:55AM MyMD Pharmaceuticals® and Charles River Present Positive Data for Next Generation, Oral TNF- Inhibitor MYMD-1® in Rheumatoid Arthritis (Business Wire) -5.00%
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. It focuses on developing and commercializing the MyMD-1 and SUPERA-CBD therapeutic platforms. MyMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune diseases. Supera-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in Baltimore, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rivard PaulChief Legal OfficerAug 24Buy1.11150,000166,500400,000Aug 24 05:58 PM
Rivard PaulChief Legal OfficerAug 17Buy1.1225,00028,080250,000Aug 18 04:21 PM
CAN - Canaan Inc ADR - Stock Price Chart
TickerCAN [NASD]
CompanyCanaan Inc ADR
IndustryComputer Hardware
Market Cap286.44MEPS (ttm)-1.99
P/E-EPS this Y-124.57%
Forward P/E-EPS next Y0.00%
PEG-EPS past 5Y3.42%
P/S1.32EPS next 5Y-
P/B0.90EPS Q/Q-1005.21%
Dividend-Sales Q/Q-76.66%
Insider Own-Inst Own30.32%
Insider Trans-Inst Trans-8.65%
Short Float14.96%EarningsFeb 27/b
Analyst Recom1.00Target Price4.18
Avg Volume20.02M52W Range1.13 - 3.50
Canaan, Inc. engages in the provision of computing solutions. Currently, the firm is focused on the research and development of technology, including such areas as AI chips, AI algorithms, AI architectures, system on a chip (SoC) integration and chip integration. It also provides a suite of AI service solutions. The company was founded by Li Jia Xuan, Liu Xiang Fu and Zhang Nan Geng in 2013 and is headquartered in Singapore.
PLCE - Childrens Place Inc - Stock Price Chart
CompanyChildrens Place Inc
IndustryApparel Retail
Market Cap269.43MEPS (ttm)-6.20
P/E-EPS this Y-3337.26%
Forward P/E39.78EPS next Y119.74%
PEG-EPS past 5Y-
P/S0.17EPS next 5Y-7.10%
P/B2.28EPS Q/Q-6.34%
Dividend-Sales Q/Q-5.67%
Insider Own63.43%Inst Own85.68%
Insider Trans124.01%Inst Trans-8.68%
Short Float45.52%EarningsNov 16/b
Analyst Recom3.50Target Price13.67
Avg Volume1.32M52W Range8.30 - 45.03
The Children's Place, Inc. engages in the provision of apparel, footwear, accessories, and other items for children. The firm also designs contracts to manufacture and sell fashionable and value-priced merchandise under the brand names of The Children's Place, Baby Place, and Gymboree. It operates through The Children's Place U.S. and The Children's Place International segments. The Children's Place U.S. segment refers to the company's U.S. and Puerto Rico-based stores and revenue from its U.S. based wholesale business. The Children's Place International segment is involved in the Canadian-based stores, revenue from the company's Canadian-based wholesale business, as well as revenue from international franchisees. The company was founded by David Pulver and Clinton A. Clark in 1969 and is headquartered in Secaucus, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mithaq Capital SPC10% OwnerFeb 13Buy11.15966,34410,779,0276,751,387Feb 15 03:57 PM
Mithaq Capital SPC10% OwnerFeb 12Buy15.801,566,47524,749,5254,663,743Feb 14 07:51 PM
Mithaq Capital SPC10% OwnerFeb 09Buy11.021,849,39720,387,1783,097,268Feb 13 09:11 PM
ELFERS JANE TPresident and CEOJul 05Buy23.7043,0001,019,100370,033Jul 06 08:30 AM
HKIT - Hitek Global Inc - Stock Price Chart
CompanyHitek Global Inc
IndustrySoftware - Application
Market Cap37.60MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y35.49%
P/S-EPS next 5Y-
Dividend-Sales Q/Q-
Insider Own-Inst Own1.24%
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume2.10M52W Range0.54 - 39.80
Hitek Global, Inc. is a holding company, which engages in the provision of information technology consulting and solutions. It operates through the services to small and medium businesses, which consists of anti-counterfeiting tax control system tax devices, golden tax disk and printers, and information technology services; and services to hardware and software sales business lines. The company was founded by Shen Ping Yin on November 3, 2017 and is headquartered in Xiamen, China.
EQ - Equillium Inc - Stock Price Chart
TickerEQ [NASD]
CompanyEquillium Inc
Market Cap93.77MEPS (ttm)-0.24
P/E-EPS this Y72.97%
Forward P/E-EPS next Y49.00%
PEG-EPS past 5Y-70.20%
P/S2.20EPS next 5Y-
P/B3.89EPS Q/Q73.23%
Dividend-Sales Q/Q-
Insider Own63.96%Inst Own7.53%
Insider Trans0.00%Inst Trans2.52%
Short Float4.10%EarningsNov 08/a
Analyst Recom1.00Target Price6.50
Avg Volume321.21K52W Range0.45 - 3.09
Equillium, Inc. engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly on March, 2017 and is headquartered in La Jolla, CA.
MGIH - Millennium Group International Holdings Ltd - Stock Price Chart
CompanyMillennium Group International Holdings Ltd
CountryHong Kong
IndustryPackaging & Containers
Market Cap22.05MEPS (ttm)-0.08
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.48EPS next 5Y-
P/B0.55EPS Q/Q-238.07%
Dividend-Sales Q/Q-36.57%
Insider Own88.89%Inst Own0.20%
Insider Trans0.00%Inst Trans-
Short Float0.03%Earnings-
Analyst Recom-Target Price-
Avg Volume1.74M52W Range0.89 - 9.57
Millennium Group International Holdings Ltd. is a paper-based packaging solutions supplier. It engages in the business of production and sale of packaging products and corrugated products. Its integrated business processes include market research, research and development, packaging design and development, raw materials procurement, color management, product testing, quality control and delivery services. The company was founded by Yee Cheong Lai in 1978 and is headquartered in Hong Kong.
S - SentinelOne Inc - Stock Price Chart
TickerS [NYSE]
CompanySentinelOne Inc
IndustrySoftware - Infrastructure
Market Cap7.76BEPS (ttm)-1.24
P/E-EPS this Y58.44%
Forward P/E412.56EPS next Y121.64%
PEG-EPS past 5Y-
P/S13.54EPS next 5Y40.20%
P/B4.89EPS Q/Q32.73%
Dividend-Sales Q/Q42.35%
Insider Own23.07%Inst Own61.28%
Insider Trans-10.76%Inst Trans11.47%
Short Float4.15%EarningsMar 13/a
Analyst Recom2.03Target Price28.43
Avg Volume6.58M52W Range12.43 - 30.76
SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weingarten TomerPresident, CEOFeb 09Sale29.9647,3651,418,951787,474Feb 09 08:16 PM
Bernhardt David J.Chief Financial OfficerFeb 09Sale30.0334,0211,021,657403,132Feb 09 09:26 PM
Weingarten TomerPresident, CEOFeb 08Sale28.9747,3651,372,137787,474Feb 09 08:16 PM
Weingarten TomerPresident, CEOFeb 07Sale28.359,791277,547787,474Feb 09 08:16 PM
Smith RicCPO & CTOFeb 07Sale28.353,946111,859451,428Feb 09 07:23 PM
PTIX - Protagenic Therapeutics Inc - Stock Price Chart
CompanyProtagenic Therapeutics Inc
Market Cap3.96MEPS (ttm)-0.91
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y1.32%
P/S-EPS next 5Y-
P/B0.93EPS Q/Q-50.63%
Dividend-Sales Q/Q-
Insider Own19.99%Inst Own7.96%
Insider Trans0.91%Inst Trans-1.72%
Short Float0.40%Earnings-
Analyst Recom1.00Target Price16.00
Avg Volume7.50K52W Range0.68 - 2.32
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Arrow Alexander K.Chief Financial OfficerOct 12Buy0.818,0006,48045,815Oct 13 12:48 PM